Bacterial microbiome profiles of the inflamed terminal ileum mucosa in active Crohn’s disease patients
PeerJ · 2025
DOI: 10.7717/peerj.19959 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Juan Yin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Disease and Nutrition Research Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospita…. Hauptthemen laut MEDLINE: Crohn Disease, Intestinal Mucosa, Gastrointestinal Microbiome, Ileum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science and Technology Plan of Suzhou Citizens’ Health, Suzhou Special Project of Diagnosis and Treatment for Key Clinical Disease, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Background
The dysbiosis of the intestinal microbiome relates to the pathogenesis of Crohn’s disease (CD). Previous studies have focused on microbiota diversity and composition in CD patients in comparison with healthy individuals. Nonetheless, intestinal flora varies greatly among individuals. This study aimed to characterize the bacterial microbiome profiles of inflamed mucosa in comparison with those of noninflamed mucosa from Crohn’s disease patients.
Methods
Sequencing of 16S rDNA V4 was used to identify the bacterial microbiome profiles of twelve pairs of inflamed and noninflamed mucosa from active CD patients.
Results
A total of 753 OTUs were specific to inflamed tissues. Alpha diversity demonstrated that the biodiversity of the bacterial microbiota in the inflamed mucosa was increased, but it was not significantly different from that in the noninflamed mucosa. Linear discriminant analysis effect size (LEfSe) Clustergram showed Micrococcaceae , Bifidobacteriaceae , Bifidobacteriales , Flavobacteriaceae , and Methylobacteriaceae as microbes that were significantly different in the inflamed mucosa of active CD patients. Wilcox test results of genus differences indicated Methylobacterium, Rothia, Shinella, Capnocytophaga, Actinomyces, Gardnerella, Leucobacter , and Bifidobacterium as significantly upregulated genera in the inflamed mucosa of active CD patients compared with their noninflamed mucosa. These findings provide new evidence that the dysbiosis of mucosa-associated microbiota contributes to CD development, from a self-comparison perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Digestive Disease and Nutrition Research Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China.
- Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China.
Förderung
- Science and Technology Plan of Suzhou Citizens’ Health
- Suzhou Special Project of Diagnosis and Treatment for Key Clinical Disease
- Natural Science Foundation of Jiangsu Province
- Gut Microbiota Research Project of Gusu School, Nanjing Medical University
- The Gut Microbiota Research Project of Gusu School, Nanjing Medical University
Zitieren
APA
Yin, J., Hu, T., Zhang, L., Xu, L., Zhu, J., Ye, Y., & Pang, Z. (2025). Bacterial microbiome profiles of the inflamed terminal ileum mucosa in active Crohn’s disease patients. PeerJ. https://doi.org/10.7717/peerj.19959
Vancouver
Yin J, Hu T, Zhang L, Xu L, Zhu J, Ye Y, et al. Bacterial microbiome profiles of the inflamed terminal ileum mucosa in active Crohn’s disease patients. PeerJ. 2025. doi:10.7717/peerj.19959
BibTeX
@article{Yin2025,
author = {Yin, Juan and Hu, Tong and Zhang, Liping and Xu, Lijuan and Zhu, Jianyun and Ye, Yulan and Pang, Zhi},
title = {Bacterial microbiome profiles of the inflamed terminal ileum mucosa in active Crohn’s disease patients},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19959}
}
EUVIMED